Chemoinformaics analysis of Lysophosphatidylcholine
Molecular Weight | 299.26 | nRot | 9 |
Heavy Atom Molecular Weight | 277.084 | nRig | 2 |
Exact Molecular Weight | 299.113 | nRing | 0 |
Solubility: LogS | -0.155 | nHRing | 0 |
Solubility: LogP | -2.736 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
nHA | 7 | APOL | 41.7134 |
nHD | 1 | BPOL | 40.0026 |
QED | 0.335 |
Synth | 4.16 |
Natural Product Likeliness | 1.211 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.012 |
HIA | 0.263 |
CACO-2 | -5.939 |
MDCK | 0.00031593 |
BBB | 0.201 |
PPB | 0.101879 |
VDSS | 0.432 |
FU | 0.962404 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.254 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.044 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.305 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.623 |
CYP3a4-inh | 0.008 |
CYP3a4-sub | 0.07 |
CL | 1.703 |
T12 | 0.953 |
hERG | 0.028 |
Ames | 0.155 |
ROA | 0.086 |
SkinSen | 0.347 |
Carcinogencity | 0.741 |
EI | 0.038 |
Respiratory | 0.132 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.731649 |